These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 13475002)

  • 21. [Side-effects of oral antidiabetics].
    Yawata M; Morita T
    Nihon Rinsho; 1968 Jul; 26(7):1627-32. PubMed ID: 4884329
    [No Abstract]   [Full Text] [Related]  

  • 22. Influence of chlorpropamide upon post-pancreatectomy and spontaneous diabetes.
    PINES KL; LEIFER E; GOODMAN D
    Ann N Y Acad Sci; 1959 Mar; 74(3):997-1002. PubMed ID: 13637644
    [No Abstract]   [Full Text] [Related]  

  • 23. The effect of sulfonylureas on the respiratory quotient in diabetic and normal animals.
    CERLETTI P; GREGOLIN C
    Clin Chim Acta; 1959 Jul; 4():579-82. PubMed ID: 13808852
    [No Abstract]   [Full Text] [Related]  

  • 24. Effect of Metformin on Hypothalamic-Pituitary-Thyroid Axis Activity in Elderly Antipsychotic-Treated Women With Type 2 Diabetes and Subclinical Hypothyroidism: A Preliminary Study.
    Krysiak R; Szkróbka W; Okopień B
    J Clin Pharmacol; 2018 May; 58(5):586-592. PubMed ID: 29251783
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The clinical response and the amount of insulin extractable from the pancreas in diabetic patients treated with oral hypoglycaemic drugs: a report on five cases.
    BOGOCH A; DAVIS TW; JOW E; WRENSHALL GA
    Can Med Assoc J; 1959 Sep; 81(5):347-56. PubMed ID: 13802132
    [No Abstract]   [Full Text] [Related]  

  • 26. [The behavior of the blood insulin after administration of chlorpropamide in diabetic subjects].
    RODARI T; MAGGI G; SPECCHIA G
    Folia Endocrinol Mens Incretologia Incretoterapia; 1961 Oct; 14():625-31. PubMed ID: 14493077
    [No Abstract]   [Full Text] [Related]  

  • 27. [Modification of the blood glucagon level by treatment with chlorpropamide in diabetic patients].
    MAGGI G; RODARI T; GAMBA G
    Rev Iber Endocrinol; 1962; 9():93-5. PubMed ID: 14468276
    [No Abstract]   [Full Text] [Related]  

  • 28. [Behavior of the blood glucagon in diabetic subjects under treatment with chlorpropamide].
    MAGGI G; RODARI T; GAMBA G
    Folia Endocrinol Mens Incretologia Incretoterapia; 1961 Oct; 14():641-9. PubMed ID: 14468275
    [No Abstract]   [Full Text] [Related]  

  • 29. [Variations in the blood cholesterol level in the diabetic during treatment with chlorpropamide].
    BERETTA P; PUNTURIERI E
    Minerva Med; 1959 Aug; 50():2562-3. PubMed ID: 13799184
    [No Abstract]   [Full Text] [Related]  

  • 30. [Comparison between sensitivity to chlorpropamide and to other oral hypoglycemic agents in diabetes mellitus].
    PALMAS S
    Minerva Med; 1959 Aug; 50():2570-3. PubMed ID: 14429972
    [No Abstract]   [Full Text] [Related]  

  • 31. [Effects of oral antidiabetics (N-tolyl-sulfonyl-N'-butyl urea) on thyroid function and serum cholesterol in the rat].
    ANTILA V; KUUSISTO AN; HARTEL G
    Ann Med Exp Biol Fenn; 1957; 35(3):272-6. PubMed ID: 13470499
    [No Abstract]   [Full Text] [Related]  

  • 32. The effects of hypoglycemia induced by agents other than exogenous insulin on duodenal motility in dogs under morphine-chloralose anesthesia: I. The arylsulfonylureas.
    BUNAG RD; RIGOR BM; TAN-GATUE LG; REOTUTAR WR; GUEVARA R
    J Philipp Med Assoc; 1959 Oct; 35():656-62. PubMed ID: 13805904
    [No Abstract]   [Full Text] [Related]  

  • 33. The effects of chlorpropamide on endocrine function in patients with diabetes mellitus and its effects in other endocrine disorders.
    HAMWI GJ; SKILLMAN TG; KRUGER FA; FREEDY LR
    Ann N Y Acad Sci; 1959 Mar; 74(3):1003-11. PubMed ID: 13637645
    [No Abstract]   [Full Text] [Related]  

  • 34. Metabolic effects of phenethylbiguanide in normal subjects and in diabetic patients.
    FAJANS SS; MOORHOUSE JA; DOORENBOS H; LOUIS LH; CONN JW
    Diabetes; 1960; 9():194-201. PubMed ID: 13821364
    [No Abstract]   [Full Text] [Related]  

  • 35. Observations on the mode of action and clinical effects of chlorpropamide in diabetes mellitus.
    LEEVY CM; TORNOW A; GREENBERG P; ZINKE M
    Ann N Y Acad Sci; 1959 Mar; 74(3):725-37. PubMed ID: 13637614
    [No Abstract]   [Full Text] [Related]  

  • 36. Antihyperglycaemic and antiperoxidative roles of acarbose in type 2 diabetes mellitus are possibly mediated through changes in thyroid function.
    Rameshwar J; Anand K
    Clin Exp Pharmacol Physiol; 2006 Nov; 33(11):1104-6. PubMed ID: 17042922
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Drug influence of iodine metabolism in the thyroid gland and its functional diagnosis].
    Foldenauer A; Böhm P
    Dtsch Med Wochenschr; 1970 Jul; 95(27):1454-8. PubMed ID: 4194108
    [No Abstract]   [Full Text] [Related]  

  • 38. [The effect of orally administered biguanide and sulfonylurea with reference to a test for latent diabetes mellitus].
    GUTSCHE H
    Arzneimittelforschung; 1961 Dec; 11():1127-30. PubMed ID: 13903204
    [No Abstract]   [Full Text] [Related]  

  • 39. [The dynamics of bone marrow hematopoiesis in patients with diabetes mellitus during treatment with preparations with hypoglycemic action].
    KRASNOVA AM
    Probl Gematol Pereliv Krovi; 1961 Aug; 6():33-5. PubMed ID: 14459367
    [No Abstract]   [Full Text] [Related]  

  • 40. [Oral antidiabetics (hypoglycemic sulfamides and biguanides)].
    Vigne J
    Brux Med; 1974 Feb; 54(2):91-7. PubMed ID: 4434244
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.